aTyr Pharma reported $1.81M in Debt for its fiscal quarter ending in March of 2026.





Debt Change Date
Alterity Therapeutics Limited AUD 210.39K 120.67K Jun/2023
Ardelyx USD 208.26M 653K Mar/2026
aTyr Pharma USD 1.81M 29K Mar/2026
Biogen USD 6.56B 275.1M Mar/2026
Bristol-Myers Squibb USD 47.14B 3.9B Dec/2025
Cipla INR 4.38B 231.9M Mar/2025
Clal Biotechnology ILS 35.76M 28.27M Dec/2023
Compugen USD 2.93M 14K Mar/2026
CSL USD 11.96B 219M Dec/2024
Curis USD 0 0 Jun/2022
GlaxoSmithKline GBP 19.06B 1.34B Mar/2026
Grifols EUR 9.23B 626.05M Dec/2024
Lakefront Biotherapeutics EUR 6.44M 480K Mar/2026
Novartis USD 47B 11.62B Mar/2026
Roche Holding CHF 33.03B 1.41B Jun/2025
United Therapeutics USD 200M 100M Mar/2025